BioRegenx's total assets for Q1 2026 were $337.07K, a decrease of -17.99% from the previous quarter. BRGX total liabilities were $4.87M for the fiscal quarter, a -1.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.